TY - JOUR
T1 - Clinical isolates of Mycobacterium simiae in San Antonio, Texas
T2 - An 11-yr review
AU - Valero, Gustavo
AU - Peters, Jay
AU - Jorgensen, James H.
AU - Graybill, John R.
N1 - Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 1995/11
Y1 - 1995/11
N2 - During a period of 11 yr (1983-1993) 137 clinical isolates of Mycobacterium simiae obtained from 75 patients were identified in a University hospital in San Antonio, Texas. One hundred twenty-eight isolates (93%) were from a pulmonary source, four (3%) from blood, and five from other sites including skin, urine, lymph node, bone marrow, and brain. Of 62 evaluable patients, six (10%) had definite infection, nine (14%) had probable disease, and 48 (76%) were thought to be colonized. During the last 2 yr of the study (1992 and 1993), M. simiae became the second most frequently isolated non-tuberculous mycobacterium at this institution surpassed only by Mycobacterium avium complex. There are limited data about effective treatment for this multidrug-resistant organism. New macrolides, quinolones, ethambutol, clofazimine, and aminoglycosides are promising therapeutic agents.
AB - During a period of 11 yr (1983-1993) 137 clinical isolates of Mycobacterium simiae obtained from 75 patients were identified in a University hospital in San Antonio, Texas. One hundred twenty-eight isolates (93%) were from a pulmonary source, four (3%) from blood, and five from other sites including skin, urine, lymph node, bone marrow, and brain. Of 62 evaluable patients, six (10%) had definite infection, nine (14%) had probable disease, and 48 (76%) were thought to be colonized. During the last 2 yr of the study (1992 and 1993), M. simiae became the second most frequently isolated non-tuberculous mycobacterium at this institution surpassed only by Mycobacterium avium complex. There are limited data about effective treatment for this multidrug-resistant organism. New macrolides, quinolones, ethambutol, clofazimine, and aminoglycosides are promising therapeutic agents.
UR - http://www.scopus.com/inward/record.url?scp=0028886652&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028886652&partnerID=8YFLogxK
U2 - 10.1164/ajrccm.152.5.7582293
DO - 10.1164/ajrccm.152.5.7582293
M3 - Article
C2 - 7582293
AN - SCOPUS:0028886652
SN - 1073-449X
VL - 152
SP - 1555
EP - 1557
JO - American Journal of Respiratory and Critical Care Medicine
JF - American Journal of Respiratory and Critical Care Medicine
IS - 5 I
ER -